FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803972431> ?p ?o ?g. }

• W2803972431 endingPage "253" @default.
• W2803972431 startingPage "239" @default.
• W2803972431 abstract "Diffuse leptomeningeal glioneuronal tumors (DLGNT) represent rare CNS neoplasms which have been included in the 2016 update of the WHO classification. The wide spectrum of histopathological and radiological features can make this enigmatic tumor entity difficult to diagnose. In recent years, large-scale genomic and epigenomic analyses have afforded insight into key genetic alterations occurring in multiple types of brain tumors and provide unbiased, complementary tools to improve diagnostic accuracy. Through genome-wide DNA methylation screening of > 25,000 tumors, we discovered a molecularly distinct class comprising 30 tumors, mostly diagnosed histologically as DLGNTs. Copy-number profiles derived from the methylation arrays revealed unifying characteristics, including loss of chromosomal arm 1p in all cases. Furthermore, this molecular DLGNT class can be subdivided into two subgroups [DLGNT methylation class (MC)-1 and DLGNT methylation class (MC)-2], with all DLGNT-MC-2 additionally displaying a gain of chromosomal arm 1q. Co-deletion of 1p/19q, commonly seen in IDH-mutant oligodendroglioma, was frequently observed in DLGNT, especially in DLGNT-MC-1 cases. Both subgroups also had recurrent genetic alterations leading to an aberrant MAPK/ERK pathway, with KIAA1549:BRAF fusion being the most frequent event. Other alterations included fusions of NTRK1/2/3 and TRIM33:RAF1, adding up to an MAPK/ERK pathway activation identified in 80% of cases. In the DLGNT-MC-1 group, age at diagnosis was significantly lower (median 5 vs 14 years, p < 0.01) and clinical course less aggressive (5-year OS 100, vs 43% in DLGNT-MC-2). Our study proposes an additional molecular layer to the current histopathological classification of DLGNT, of particular use for cases without typical morphological or radiological characteristics, such as diffuse growth and radiologic leptomeningeal dissemination. Recurrent 1p deletion and MAPK/ERK pathway activation represent diagnostic biomarkers and therapeutic targets, respectively-laying the foundation for future clinical trials with, e.g., MEK inhibitors that may improve the clinical outcome of patients with DLGNT." @default.
• W2803972431 created "2018-06-01" @default.
• W2803972431 creator A5004308269 @default.
• W2803972431 creator A5005027457 @default.
• W2803972431 creator A5005354758 @default.
• W2803972431 creator A5006000088 @default.
• W2803972431 creator A5008206204 @default.
• W2803972431 creator A5010036887 @default.
• W2803972431 creator A5010687963 @default.
• W2803972431 creator A5014081389 @default.
• W2803972431 creator A5019220658 @default.
• W2803972431 creator A5027426012 @default.
• W2803972431 creator A5029221724 @default.
• W2803972431 creator A5030593455 @default.
• W2803972431 creator A5034125759 @default.
• W2803972431 creator A5036558579 @default.
• W2803972431 creator A5038035447 @default.
• W2803972431 creator A5039647180 @default.
• W2803972431 creator A5040991417 @default.
• W2803972431 creator A5041096535 @default.
• W2803972431 creator A5041715992 @default.
• W2803972431 creator A5043261933 @default.
• W2803972431 creator A5049570752 @default.
• W2803972431 creator A5050894746 @default.
• W2803972431 creator A5052657395 @default.
• W2803972431 creator A5053059462 @default.
• W2803972431 creator A5063134863 @default.
• W2803972431 creator A5063978061 @default.
• W2803972431 creator A5064456190 @default.
• W2803972431 creator A5071632296 @default.
• W2803972431 creator A5075358445 @default.
• W2803972431 creator A5077736287 @default.
• W2803972431 creator A5079537507 @default.
• W2803972431 creator A5085532914 @default.
• W2803972431 creator A5088806051 @default.
• W2803972431 creator A5089427177 @default.
• W2803972431 creator A5090815387 @default.
• W2803972431 date "2018-05-15" @default.
• W2803972431 modified "2023-10-11" @default.
• W2803972431 title "Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features" @default.
• W2803972431 cites W1967220865 @default.
• W2803972431 cites W1972040632 @default.
• W2803972431 cites W1977044507 @default.
• W2803972431 cites W1979167497 @default.
• W2803972431 cites W1982933697 @default.
• W2803972431 cites W1988462713 @default.
• W2803972431 cites W1997642817 @default.
• W2803972431 cites W2002742456 @default.
• W2803972431 cites W2015465253 @default.
• W2803972431 cites W2017090190 @default.
• W2803972431 cites W2018395989 @default.
• W2803972431 cites W2020797402 @default.
• W2803972431 cites W2026348437 @default.
• W2803972431 cites W2028785929 @default.
• W2803972431 cites W2044384324 @default.
• W2803972431 cites W2045309144 @default.
• W2803972431 cites W2046893599 @default.
• W2803972431 cites W2055560959 @default.
• W2803972431 cites W2073190753 @default.
• W2803972431 cites W2074591493 @default.
• W2803972431 cites W2083201803 @default.
• W2803972431 cites W2084378067 @default.
• W2803972431 cites W2092627181 @default.
• W2803972431 cites W2095222153 @default.
• W2803972431 cites W2097626332 @default.
• W2803972431 cites W2101870168 @default.
• W2803972431 cites W2117131162 @default.
• W2803972431 cites W2126595521 @default.
• W2803972431 cites W2136635565 @default.
• W2803972431 cites W2136869337 @default.
• W2803972431 cites W2169438753 @default.
• W2803972431 cites W2207035666 @default.
• W2803972431 cites W2286322195 @default.
• W2803972431 cites W2334027225 @default.
• W2803972431 cites W2335155752 @default.
• W2803972431 cites W2465783180 @default.
• W2803972431 cites W2616935389 @default.
• W2803972431 cites W2651515262 @default.
• W2803972431 cites W2787816121 @default.
• W2803972431 doi "https://doi.org/10.1007/s00401-018-1865-4" @default.
• W2803972431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29766299" @default.
• W2803972431 hasPublicationYear "2018" @default.
• W2803972431 type Work @default.
• W2803972431 sameAs 2803972431 @default.
• W2803972431 citedByCount "112" @default.
• W2803972431 countsByYear W28039724312018 @default.
• W2803972431 countsByYear W28039724312019 @default.
• W2803972431 countsByYear W28039724312020 @default.
• W2803972431 countsByYear W28039724312021 @default.
• W2803972431 countsByYear W28039724312022 @default.
• W2803972431 countsByYear W28039724312023 @default.
• W2803972431 crossrefType "journal-article" @default.
• W2803972431 hasAuthorship W2803972431A5004308269 @default.
• W2803972431 hasAuthorship W2803972431A5005027457 @default.
• W2803972431 hasAuthorship W2803972431A5005354758 @default.
• W2803972431 hasAuthorship W2803972431A5006000088 @default.
• W2803972431 hasAuthorship W2803972431A5008206204 @default.
• W2803972431 hasAuthorship W2803972431A5010036887 @default.

• next